Metabolic and Dietary Influences on Sympathetic Nervous System Activity

1. Hoffman RP, Sinkey CA, EA Anderson. Microneurographically determined muscle sympathetic nerve activity levels are reproducible in insulin-dependent diabetes mellitus. J Diabetes Complications 1998;12(6): 307–10. 2. Huggett RJ, Scott EM, Gilbey SG, et al. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003;108(25):3097–101. 3. Huggett RJ, Hogarth AJ, Mackintosh AF, et al. Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia 2006;49(11):2741–4. 4. Berne C, Fagius J, Pollare T, et al. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992;35(9):873–9. 5. Muntzel MS, Anderson EA, Johnson AK, et al, Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 1995;17(1-2):39–50. 6. Tack CJ, Smits P, Willemsen JJ, et al. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 1996;45(1):15–22. 7. Perciaccante A, Fiorentini A, Paris A, et al. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 2006;6:19. 8. Hoffman RP, Sinkey CA, Kienzle MG, et al. Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy. Diabetes 1993;42(3): 375–80. 9. Bernardi L, Ricordi L, Lazzari P, et al. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992;86(5):1443–52. 10. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93(5):1043–65. 11. Fiorentini A, Perciaccante A, Paris A, et al. Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients. Cardiovasc Diabetol 2005;4:15. 12. Carnethon MR, Golden SH, Folsom AR, et al. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study 1987–1998. Circulation 2003;107(17):2190–5. 13. Landsberg L. Feast or famine: the sympathetic nervous system response to nutrient intake. Cell Mol Neurobiol 2006;26(4-6):497–508. 14. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the ’chicken-and-egg’ question. J Hypertens 1994;12(5):495–502. 15. Masuo K, Mikami H, Ogihara T, et al. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997;10(1):77–83. 16. Grassi G, M Esler. How to assess sympathetic activity in humans. J Hypertens 1999;17(6):719–34. 17. Rocchini AP, Mao HZ, Babu K, et al. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999;33(1 Pt 2):548–53. 18. Huggett RJ, Burns J, Mackintosh AF, et al. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004;44(6):847–52